Survey reveals patients’ thoughts on trial participation
Conducted by SubjectWell, the survey of patients with Type 2 diabetes reveals how ethnicity and other factors play a part in trial participation tendencies.
Archives for January 25, 2021
eCOA tech helps trials tackle COVID-19 obstacles: IQVIA
Two leaders from the clinical technology solutions company discuss how digital tools like eCOAs have been invaluable in facing pandemic-related challenges.
FDA approves injectable treatment for HIV patients
The agency has given the thumbs up to ViiV’s once-a-month Cabenuva, the first FDA-approved injectable, complete regimen for adults diagnosed with HIV.